About KM Management spol. s r.o.
Clinical Trials at KM Management spol. s r.o.
During the past decade, KM Management spol. s r.o. conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 25 clinical trials were completed, i.e. on
average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 19 clinical trials were completed. i.e. 271.4%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "KM Management spol. s r.o." #1 sponsor was "Pfizer" with 10 trials, followed by "Celgene" with 7 trials
sponsored, "Shire" with 7 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Galapagos NV"
with 4 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "KM Management spol. s r.o."
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator and "Galapagos NV" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 3 trials.
Clinical Trials Conditions at KM Management spol. s r.o.
According to Clinical.Site data, the most researched conditions in "KM Management spol. s r.o." are
"Ulcerative Colitis" (19 trials), "Crohn's Disease" (10 trials), "Crohn Disease" (7 trials), "Colitis, Ulcerative" (4 trials) and "Chronic Idiopathic Constipation" (1 trials). Many other conditions were trialed in "KM Management spol. s r.o." in a lesser frequency.
Clinical Trials Intervention Types at KM Management spol. s r.o.
Most popular intervention types in "KM Management spol. s r.o." are "Drug" (40 trials), "Other" (8 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (23 trials), "Etrasimod" (4 trials), "Etrolizumab" (4 trials), "Filgotinib" (4 trials) and "GED-0301" (4 trials). Other intervention names were less common.
Clinical Trials Genders at KM Management spol. s r.o.
The vast majority of trials in "KM Management spol. s r.o." are
42 trials for "All" genders.
Clinical Trials Status at KM Management spol. s r.o.
Currently, there are NaN active trials in "KM Management spol. s r.o.".
undefined are not yet recruiting,
6 are recruiting,
7 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 20 completed trials in KM Management spol. s r.o.,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in KM Management spol. s r.o., 1 "Phase 1"
clinical trials were conducted, 7 "Phase 2" clinical
trials and 33 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".